C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
08/2006
08/09/2006	EP1687302A1 5-substituted imidazoles
08/09/2006	EP1687291A2 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof
08/09/2006	EP1658366A4 Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof
08/09/2006	EP1252889B1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
08/09/2006	EP1140828B1 3-azabicyclo¬3.1.0\|hexane derivatives as opiate receptors ligands
08/09/2006	CN1816529A Pyrazole-amide compounds useful as kinase inhibitors
08/09/2006	CN1816370A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
08/09/2006	CN1816341A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
08/09/2006	CN1268322C Pharmaceutical compositions comprising amlodipine maleate
08/08/2006	US7087755 2-substituted pyridine-4-boronic acids created by reacting a metallated pyridine with an electrophile; useful in combinatorial approaches by virtue of their boronic moiety and at least one additional functional group
08/08/2006	US7087603 Pyrazole compounds useful as protein kinase inhibitors
08/03/2006	US20060173193 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases
08/03/2006	US20060173032 Isolation and structure of cribrostatin 6
08/03/2006	US20060171966 Variants of vibrio cholerae 01 biotype e1 tor with attributes of classical biotype
08/02/2006	EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
08/02/2006	EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases
08/02/2006	EP1686113A1 Inhibitors of aspartyl protease
08/02/2006	EP1073637B1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
08/02/2006	CN1812982A Benzodiazepine cgrp receptor antagonists
08/02/2006	CN1810802A 3-substituted-4-pyrimidone derivatives
08/01/2006	US7084168 Indoline derivatives
08/01/2006	US7084144 Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction
08/01/2006	CA2188400C Preparation of arthropodicidal oxadiazines
07/2006
07/27/2006	US20060167108 Neuroprotective benzoate and benzamide compounds
07/27/2006	US20060167004 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
07/27/2006	US20060166980 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
07/27/2006	US20060166979 for prophylaxis and treatment of atrial and ventricular arrhythmias
07/27/2006	US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct
07/26/2006	EP1682512A2 Immunohistochemical methods
07/26/2006	EP1682139A1 Preparation of pharmaceutical salts of 1, 4 - bipiperidine
07/26/2006	EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof
07/26/2006	CN1809567A Novel imidazopyridine compound ii with therapeutic effect
07/26/2006	CN1809553A Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
07/20/2006	WO2004108668A3 Alpha-7 neuronal nicotinic receptor ligands: compositions and methods of use
07/20/2006	US20060161006 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
07/20/2006	US20060160882 Indoline derivatives
07/20/2006	US20060160879 Indoles useful in the treatment of inflammation
07/20/2006	US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
07/19/2006	EP1681058A2 Pharmacologically active cns compounds
07/19/2006	EP1680131A2 Substituted indole-o-glucosides
07/19/2006	EP1679966A2 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
07/19/2006	CN1805965A Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
07/19/2006	CN1805963A Cannabinoid receptor ligands and uses thereof
07/19/2006	CN1805957A Azetidine compounds
07/19/2006	CN1805956A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
07/19/2006	CN1805948A Stabilized derivatives of ascorbic acid.
07/19/2006	CN1805940A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
07/18/2006	US7078521 By reaction of pyrrolobenzothiazepin-9-one with amine to give the corresponding enamine, which is subsequently transformed into the final compound
07/18/2006	US7078430 3-carbamoyl-pyran that is n-derivatized by dihydroxyheptanoic acid or 6-ethyl-4-hydroxy-pyran-2-one; anticholesterol agents
07/13/2006	WO2006073367A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators
07/13/2006	WO2006073366A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/13/2006	WO2006073365A1 Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators
07/13/2006	WO2004096139A3 Aza spiro alkane derivatives as inhibitors of metalloproteases
07/13/2006	US20060154964 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/13/2006	CA2594404A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/12/2006	EP1678499A2 Chemical compound and assay
07/12/2006	EP1678196A1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
07/12/2006	EP1678156A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
07/12/2006	EP1678131A2 Methods for making simvastatin and intermediates
07/12/2006	EP1677797A2 Salts and polymorphs of a potent antidiabetic compound
07/12/2006	EP1677794A2 Methods of treating disorder
07/12/2006	EP1677791A2 Nitrogen-containing fused heterocyclic compounds
07/12/2006	EP1677767A2 Crystalline form of gamma-aminobutyric acid analog
07/12/2006	CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
07/12/2006	CN1802153A Treatment of cognitive impairment using a selective dopamine D1 receptor agonist
07/12/2006	CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
07/12/2006	CN1800175A Amino alcohol derivatives
07/12/2006	CN1263758C 3,7-diazabicyclo[3,3,o] otanes and their use in treatment of cardiac arrhythmias
07/12/2006	CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof
07/11/2006	CA2274074C Novel compounds with analgesic effect
07/11/2006	CA2035972C Process for the preparation of oxetanones
07/06/2006	WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/06/2006	US20060148818 Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders
07/06/2006	US20060148790 Benzodiazepine cgrp receptor antagonists
07/06/2006	US20060148662 Polyisobutene phosphonic acid and the derivatives thereof
07/05/2006	EP1676845A1 New quinazoline derivatives
07/05/2006	EP1675856A1 Novel tetraydrospiro{piperidine-2,7'-pyrrolo [3,2]pyridine} derivatives and novel indole derivatives useful in the treatment of 5-ht6 receptor -related disorders
07/05/2006	EP1675847A2 Spirocyclic heterocyclic derivatives and methods of their use
07/05/2006	EP1675830A2 Heterocyclic amides and sulfonamides
07/05/2006	EP1675824A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
07/05/2006	EP1675808A2 Toluene methylation process
07/05/2006	EP1675570A2 Use of photodynamic therapeutic agents entrapped in ceramic nanoparticles
07/05/2006	EP1259240B1 Agents, such as nicotinamide or cadpr for the treatment of skin disorders
07/05/2006	EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
07/05/2006	CN1798747A Kondensierte pyrazol derivate als protein kinase inhibitoren
07/05/2006	CN1798741A Improved production of rosuvastatin calcium salt
07/05/2006	CN1798726A Substituted indoles and a process for preparing substituted indoles
07/05/2006	CN1798504A Alkoxy alkylsulfanyl phenols
07/05/2006	CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative
07/05/2006	CN1262536C Production of pyridazine herbicides
07/04/2006	CA2364719C 2-aminopyridines containing fused ring substituents
06/2006
06/29/2006	WO2006068618A1 New compounds
06/29/2006	WO2006068617A1 A new manufacturing process for the preparation of halogen substituted 4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione
06/29/2006	WO2006068593A1 New benzothiazolesulfonamides
06/29/2006	WO2006068592A1 New benzothiazolecarboxamides
06/29/2006	WO2006067385A1 Chemical compounds
06/29/2006	US20060142571 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines
06/29/2006	US20060142364 2-tert-Butyl-1-(cyclohexylmethyl)-N,N-bis(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide; treating pain
06/29/2006	US20060142357 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
06/29/2006	US20060142284 Cyclin dependent kinases (CDK2) inhibitors; 4-[5-(3-bromo-phenyl)-2H-pyrazol-3-ylamino]-benzenesulfonamide; cancer and hyperproliferative diseases, such as psoriasis

1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 105